Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Devang Kantesaria Insider Profile
4 Followers
Devang Kantesaria, Ten Percent Owner at Rocket Pharmaceuticals, holds 3.24M shares in Rocket Pharmaceuticals (Ticker: RCKT). Most recently, Devang Kantesaria Bought $814,166 shares of Rocket Pharmaceuticals on Feb 25, 2015 for an estimated value of 4.88M.
Devang Kantesaria has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Devang Kantesaria's holdings
Insider Roles
Ten Percent Owner
Roles that Devang Kantesaria holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Devang Kantesaria
Devang Kantesaria's Trading History
List of latest transactions for each holding click on a transaction to see Devang Kantesaria's performance on stock
You May Also Like
Devang Kantesaria insider profile FAQ
What is the percentage of profitable transactions made by Devang Kantesaria?
The percentage of profitable transactions made by Devang Kantesaria is ―.
What is the average return per transaction made by Devang Kantesaria?
The average return per transaction made by Devang Kantesaria is ―.
What stocks does Devang Kantesaria hold?
Devang Kantesaria holds: RCKT stocks.
What was Devang Kantesaria’s latest transaction?
Devang Kantesaria latest transaction was an Informative Buy of $4.88M.
What was Devang Kantesaria's most profitable transaction?
Devang Kantesaria’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Devang Kantesaria's role in Rocket Pharmaceuticals?
Devang Kantesaria's role in Rocket Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.